Monday, August 28, 2023
Sarepta Therapeutics to Collaborate With Lexeo on Heart Disease Gene Therapy Pipeline
Aug 28, 2023, NEW YORK – Sarepta Therapeutics has invested an undisclosed sum in Lexeo Therapeutics, and the two companies on Monday said they will explore opportunities to further develop gene therapies in Lexeo's preclinical pipeline for cardiovascular disease.
